SCHEMBL4941503

SCHEMBL4941503

CN(C1CCCCC1)S(=O)(=O)c1cc(-c2nnc(O)n2-c2ccccc2Cl)c(O)cc1O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 3/20 0.51
HTR2A P28223 2/20 0.41
HTR2C P28335 2/20 0.41
GAA P10253 3/20 0.39
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HTT P42858 2/20 0.39
MCOLN3 Q8TDD5 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 3/20 0.37
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
PTAFR P25105 1/20 0.36
PKM P14618 2/20 0.36
TP53 P04637 2/20 0.35
MAPT P10636 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4937766 0.88 HSP90AA1 (0.48) HSP90AA1HTR2AHTR2CALDH1A1L3MBTL1
SCHEMBL4939580 0.85 HSP90AA1 (0.58) HSP90AA1GAAALDH1A1MEN1KMT2A
SCHEMBL4939553 0.83 HSP90AA1 (0.70) HSP90AA1GAAALDH1A1MAPTSMN1; SMN2
SCHEMBL4933407 0.82 HSP90AA1 (0.55) HSP90AA1GAAALDH1A1HTTLMNA
SCHEMBL4940684 0.81 HSP90AA1 (0.53) HSP90AA1GAAALDH1A1KMT2AHTT
SCHEMBL4937144 0.80 HSP90AA1 (0.53) HSP90AA1GAAALDH1A1MEN1KMT2A
SCHEMBL645464 0.80 HSP90AA1 (0.58) HSP90AA1GAAALDH1A1TSHRTP53
SCHEMBL1628860 0.80 HSP90AA1 (0.45) HSP90AA1HTR2AHTR2CGAAALDH1A1
SCHEMBL4940502 0.79 HSP90AA1 (0.47) HSP90AA1GAAALDH1A1KDM4EHTT
SCHEMBL646642 0.79 HSP90AA1 (0.52) HSP90AA1ALDH1A1LMNATP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8618285-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2013-12-31 US claimed
EP-1853570-B1 HSP90-INHIBITING TRIAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2012-10-24 EP claimed
US-20080182857-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-07-31 US claimed
CN-101119978-A HSP90-inhibiting triazole derivatives MERCK PATENT GMBH (DE) 2008-02-06 CN claimed
US-8618285-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2013-12-31 US disclosed
EP-1853570-B1 HSP90-INHIBITING TRIAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2012-10-24 EP disclosed
CN-101119978-B HSP 90-inhibiting triazole derivatives MERCK PATENT GMBH 2012-05-23 CN disclosed
US-20080182857-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-07-31 US disclosed
CN-101119978-A HSP90-inhibiting triazole derivatives MERCK PATENT GMBH (DE) 2008-02-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182857-A1 Triazole Derivatives HSP90AB1, HSP90AA1, HSP90B1 HSP90AA1 2/4885HTR2A 2456/4885HTR2C 2498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.